The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010

Tentative Conference Program


February 1– 4, 2010, Dubai Men’s College, Dubai, UAE

Quick Links:

9.45 a.m.`

Delegates to be seated

10.15 a.m.
10:30 a.m.

Arrival of Chief Guest and VIPs in the Majlis

10.30 a.m.

National Anthem

10.33 a.m.

A HCT student MC welcomes the delegates

10:34 a.m.

MC to invite H.E. to deliver the Opening Address

10.35 a.m.

Opening address - H.E. Sheikh Nahayan Mabarak Al-Nahayan (Patron 2nd ICDDT)

10.50 a.m.

Conference co-President's welcome address - Prof. Dr. Atta-ur-Rahman, FRS

11.00 a.m.

Keynote Address of Prof. Dr. Ferid Murad, (Nobel Laureate & co-President, 2nd ICDDT)

11.15 a.m.

Vote of Thanks by the student MC

11.20 a.m.

Opening of the Exhibition by Sheikh Nahayan

COFFEE BREAK & TOUR OF EXHIBITION BY VIPs : 11:20 a.m. - 12:00 noon
Plenary Session
Time Chairman: Ferid Murad
Co-Chairman: Atta-ur-Rahman
Location: Auditorium  Robert Huber (Nobel Laureate)
PL-1 Intracellular Proteolysis, Basic Science and Application
Location: Auditorium  Allen B. Reitz
PL-2 The Challenge of Drug Discovery in the 21st Century

LUNCH BREAK : 1:00 - 2:30 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Drug Delivery Enabling Technologies Global Roundup of Pharmaceutical Research Capabilities and Opportunities/Successful Drug Discovery from the Research Lab to the Marketplace Oncology Endothelial Dysfunction in Cardiovascular Diseases/Nanotechnology in Biomedical Research Anti-Infectives

Translational Biomedical Research

Central Nervous System

Chairman: H. Kasuya
Co-Chairman: D. Djian
Chairman: S.K. Sahoo
Co-Chairman: E. Jaffe
Chairman: A.B. Reitz
Co-Chairman: J. Guerrero
Chairman: D.L. Vesely
Co-Chairman: R. Kumar
Chairman: E. Domingo
Co-Chairman: P. Mabeta
Chairman: F.G. Njoroge
Co-Chairman: M.I. Choudhary

Chairman: J. Chandra
Co-Chairman: N.J.R. Faria

Chairman: P.A. Guertin
Co-Chairman: M. Diksic

2:30 3:00 p.m.
K. Alexandrov

Prenylome and Lipid Modifications
IL-3 W. Duan

Aptamer Therapeutics: The 21st Century's Magic Bullet of Nanomedicine
IL-4 B.M. Dunn

Global Infectious Diseases: The Potential for Protease Inhibitors in Developing New Therapeutics
IL-5 E. Arinc

Polymorphic Cytochrome P450 Enzymes: Challenges for Anticancer Drug discovery and Development
IL-6 N.H. Hadi

Erectile Dysfunction as a Predictor of Cardiovascular Disease
IL-7 J. Rello

The Number of New Agents in the Pipeline is Scarce
IL-8 T. E. Adrian

Translational Research from a Basic Science Perspective - Development of Novel Therapeutics for Cancer, Diabetes and Obesity
IL-9 F.C. Acher

Orthosteric Agonists of Group III Metabotropic Glutamate Receptors (mGluR). From Virtual Screening to Potential Therapeutic Effects
3:00 3:30 p.m.
V. Kessler

Metal Oxide Micro and Nanoparticles for Application in Targeted Drug Delivery
IL-11 M. Yamamoto

The Roles of High-Brilliant Synchrotron Radiation in Macromolecular Crystallography
IL-12 L.J.S. Knutsen

GabitrilTM – A Drug for the Treatment of Partial Seizures Acting via Inhibition of GABA Uptake
IL-13 N. Ben-Jonathan

Small Molecule Inhibitors of the Prolectin Receptor in Breast Cancer
IL-14 N. Jessel

Nanostructured and Multilayered Active Materials for Clinical Applications
IL-15 T.K. Warren

Advancement of Antisense Therapy for Filovirus Infections
IL-16 D.K. Lahiri

Current Pharmacogenomics & Epigenetic Studies in Neuropsychiatric Disorders
IL-17 G G. Yener

Brain Oscillations in Alzheimer's Disease and Their Modulation by Cholinesterase Inhibitors
COFFEE BREAK : 03.30 – 4.00 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Drug Delivery/ Drug Discovery and Therapy in the Middle East: Challenges and Opportunities Enabling Technologies Cardiovascular Oncology Nanotechnology in Biomedical Research/Biologics Anti-Infectives

Diabetes & Obesity/Proteomics & Bioinformatics

Pharmaceutical Biotechnology/Developments in Other Therapeutic Areas/Successful Drug Discovery from the Research Lab to the Marketplace

Chairman: R. Mezzenga
Co-Chairman: T. Al-Tel
Chairman: A. Persidis
Co-Chairman: S. Fredriksson
Chairman: U. Desai
Co-Chairman: D.P. Ramji
Chairman: E. Arinc
Co-Chairman: P. Gunning
Chairman: N. Jessel
Co-Chairman: F.C. Onwuka
Chairman: J. Rello
Co-Chairman: T.K. Warren

Chairman: S.P. Kalra
Co-Chairman: H. Durchschlag

Chairman: D.F. Maurizio
Co-Chairman: O.L. Franco

H. Kasuya

Development of Nicardipine Prolonged-Release Implants after Clipping for Preventing Cerebral Vasospasm: From Laboratory to Clinical Trial
IL-19 S. K. Sahoo

Application of Nanomedicine: As an Emerging Platform for Cancer Therapy
IL-20 I.M. Khachigian

Preclinical Analysis of Dnazymes Suppressing Cancer Growth, Metastasis and the Development of Other Vascular Diseases
IL-21 H. Yoshikawa

Application of Direct DNMT3A Inhibition to the Development of Inhibitors for Cancer-specific CpG Island Methylation
IL-22 T. LaBean

Self-Assembling DNA Nanostructures for Biomedical Applications
IL-23 F. G. Njoroge

From Bench to Bedside: Discovery of Boceprevir, a novel antiviral agent for treatment of Hepatitis C Virus
IL-24 B. Fromenty

Recent Discovery of the Effects of Beta-Aminoisobutyric Acid on Lipid Homeostatis. Mechanisms and Possible Relevance for the Prevention of Obesity
IL-25 K. Yasuda

On-Chip Pre-Clinical Cardiac Toxicity: Testing Compounds Beyond hERG and QT using hES/hips Cardiomyocyte Cell Network Re-Entry Model on a Chip
P. Djian

Transglutaminase and Linkage of Active Agents to Tissues
IL-27 E. Jaffe

Morpheeins-A New Pathway for Allosteric Drug Discovery
IL-28 P.L. Huang

Oleuropein and Related Compounds from Olive Plants Reduce Diet-Induced Atherosclerosis in apoE Knockout Mice
IL-29 D.L. Vesely

Four New Anticancer Drugs: Cardiovascular Hormones Treatment of Human Pancreatic, Breast and Small Cell Lung Cancers in Athymic Mice
IL-30 P. Mabeta

Nanoparticle-Based Chemotherapy Inhibits Tumor-Associated Angiogenesis in a Murine Vascular Tumor Model
IL-31 M.I. Choudhary

Discovery of Natural Anti- Infectives
IL-32 S. Lee-Huang

Oleuropein and Related Compounds from Olive Plants Modulate Adipogenesis
IL-33 R. Raghu

Structure Based Pharmacophore Design in Computer Aided Drug Discovery
R. Chaguturu

Emerging Trends in the Discovery and Development of Chemical Probes Against Novel Therapeutic Targets in Academia: A Mount Everest in the Making
IL-35 J.M. Brunel

Title Awaited
IL-36 J.D. Baxter

Development of Pharmaceuticals that Exploit the Thyroid Hormone Receptor
IL-37 A. Cherkasov

Title Awaited
IL-38 C. Godwin

Prevalence of Candida albicans Associated Gastroenteritis in Nigerian Children
IL-39 G. Gupta

Protection Against Pathogen Infection by Boosting Host Innate Immunity
IL-40 P. Hobza

In Silico” Drug Design Based on the Modified Semi-Empirical Quantum Chemical PM6 Method
IL-41 T. Tallberg

Bio-Immunotherapy, A combined Biological and Immunological Cancer Therapy Modality
C. Braeuchle

Drug Delivery: Observation of Nanoparticle Internalization and Gene Delivery by Live Cell Imaging
SL-43 M. Barton

Title Awaited
SL-44 H.I. Vapaatalo

Does the Rennin - Angiotensin System (RAS) Regulate Also Intraocular Pressure (IOP)?
SL-45 H.I. Vapaatalo

Title Awaited
SL-46 E. Osaro

The Effects of Highly Active Antiretroviral Therapy of Stavudine, Lamivudine and Nevirapine on the CD4 Lymphocyt E Count of HIV-Infected Africans: The Nigerian Experience
SL-47 L. Polonelli

Antibodies are Cryptic Reservoirs of Antiinfective, Antitumor and Immunomodulatory Peptides
SL-48 C.O. Alebiosu

Assessing the Degree of Success for Attaining Clinical Goals Among People Living with Diabetes in a Nigerian Teaching Hospital
SL-49 A.Nefzi

Combinatorial Chemistry for the Rapid Identificatin of Highly Active Compounds

Posters Session: 1:00 p.m. - 5:00 p.m. at corridor

Conference Social Mixer: 6:30 - 7:00 p.m.

The buses will leave for hotels at 7:15 p.m.

Plenary Session
Time Chairman: R. Huber
Co-Chairman: C.D. Ribas
Location: Auditorium Gordon Wallace
PL-51 Printing, Spinning and Weaving our Way into a New World of Delivery Systems
Location: Auditorium Atta-ur-Rahman
PL-52 Natural Products -- An Exciting Source of New Drugs and Pharmacophores

COFFEE BREAK: 10:30 – 11:00 a.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Drug Delivery/ Central Nervous Systems Enabling Technologies Cardiovascular/ Translational Biomedical Research Oncology Global Roundup of Pharmaceuticals Research Capabilities and Opportunities/Endothelial Dysfunction in Cardiovascular Diseases Successful Drug Discovery from the Research Lab to the Marketplace

Translational Biomedical Research/Diabetes & Obesity

Pulmonary Disorders

Chairman: K. Alexandrov
Co-Chairman: A.C. Acher
Chairman: G. Wallace
Co-Chairman: W. Duan
Chairman: P.L. Huang
Co-Chairman: M. Delmar
Chairman: N. Ben-Jonathan
Co-Chairman: E.Terpos
Chairman: B.M. Dunn
Co-Chairman: R.A. Torres
Chairman: L.J.S. Knutsen
Co-Chairman: R. Rezzani

Chairman: T.E. Adrian
Co-Chairman: S. Lee-Huang

Chairman: S.A. Fontana
Co-Chairman: J. Ho

R. Mezzenga

Self-Assembled Food Mesophases as Delivery Systems in Water Environment: State of the Art & Challenges
IL-53 S. Fredriksson

Sensitive and High Throughput Multiplexed Immunoassays for Biomarker Discovery in Biobanked Samples Using Proximity Ligation Assays and qPCR
IL-54 D.P. Ramji

The Monocyte/Macrophage as a Promising Therapeutic Target for Atherosclerosis
IL-55 P. Gunning

Development of a New Class of Anti-Cancer Chemotherapeutics which Target the Actin Cytoskeleton
IL-56 K. Stromgaard

Conversion of Natural Toxins such as the Mushroom Toxins Muscimol and Ibotenic Acid into Glutamate Receptor Ligands
IL-57 B.J. Sargent

ALB 109564 - A Novel Tubulin Inhibitor
IL-58 J. Lewis

Translational Research in Cancer: Programs of Multi-Institutional University and Industry Collaboration in Drug Discovery and Development
IL-59 C.D. Ribas

Alternatives to Oral Corticosteroids in Gina Step V Asthma Patients
A. Banga

New Technologies to Allow Transdermal Delivery of Biopharmaceuticals
IL-61 A. Persidis

Literature Based Discovery: The Biovista Platform for Clinical Outcomes Analysis
IL-62 U. Desai

Rational Design of Non-Saccharide Mimetics of Heparin
IL-63 B. Tomanek

Early Tumor Growth Affects Diagnosis and Efficacy of Molecular MRI
IL-64 K. Chibale

Discovering Drugs in Africa by Africans: Challenges and Opportunities
IL-65 J. Hutchison

Avotermin (Juvista ) - A Novel Drug in a New Therapeutic Field
IL-66 J. K. Yao

Phospholipids Turnover and Arachidonate Signaling in Schizophrenia
IL-67 A. Linden

Targeting Interleukin-17A - An Orchestrator of Neutrophil Mobilization in the Lungs
M. Hajos

Endophenotypes as Drug Targets in Psychiatric Disorders: Connecting Genetics to Pathophysiology
IL-69 S. Stahl

Affibody-Mediated Tumor Targeting for Medical Imaging and Radiotherapy Applications
IL-70 D. Garcia-Dorado

Myocardial Repurfusion Injury: An Emerging Field for Drug Therapy in Cardiovascular Disease
IL-71 V.M. Rangnekar

A Paradigm for Cancer Selective Apoptosis
IL-72 E. Domingo

New Concepts in the Invasive Evaluation of Remodeling of the Right Ventricle and Pulmonary Vasculature in Pulmonary Arterial Hypertension: Future Targets for Drug Evaluation
IL-73 L.F. Rodella

New Perspective in Pain Treatment
IL-74 N.A. Khan

Dietary Fatty Acids in the Management of Gestational Diabetes Mellitus (GDM) and Macrosomia
IL-75 P. Paggiaro

Pharmacologic Strategies for Asthma Management
P. George

The Challenges of the CNS Medicinal Chemist. The Traps to Avoid
IL-77 A. A. Oraevsky

Systems and Biomedical Applications of Optoacoustic Tomography
IL-78 A.R.K. Franklin

Extended Spectrum of Activity of Forodesine, A Purine Nucleoside Phosphorylase Inhibitor
IL-79 K. Moelling

Antiangiogenic Effect of Plasmid DNA Encoding Human Interleukin-12 in Metastatic Melanoma Patients and Combination Therapy
IL-80 J. Freund

Titlle Awaited
IL-81 R.J. Reiter

Light as a Drug: Circadian Disruption, Melatonin Suppression and Cancer
IL-82 S.P. Kalra

Gene-Transfer Technology to Combat Metabolic Disease Cluster for Lifetime
IL-83 R. Mora-Ripoll

Omalizumab in the Management of Patients with Allergic (IgE-Mediated) Asthma
LUNCH BREAK : 1:00 - 2:30 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Drug Delivery Enabling Technologies/ Successful Drug Discovery from the Research Lab to the Marketplace/Inflammation & Immunology Cardiovascular Oncology Nanotechnology in Biomedical Research Anti-Infectives

Translational Biomedical Research/Diabetes & Obesity

Pulmonary Disorders/Inflammation & Immunology

Chairman: V. Kessler Co-Chairman: P. Thordarson Chairman: P. Watt
Co-Chairman: A.A. Oraevsky
Chairman: J.D. Baxter Co-Chairman: X.L. Zheng Chairman: S. Pervaiz
Co-Chairman: M. Hassan
Chairman: T. LaBean
Co-Chairman: N.Jessel
Chairman: G. Gupta
Co-Chairman: B.L. Tekwani
Chairman: B. Fromenty
Co-Chairman: H.M. Amin

Chairman: P. Paggiaro
Co-Chairman: R. Mora-Ripoll

G. Fricker

Drug Delivery to the Brain by Polymeric Nanparticles
SL-85 A.K. Pantazis

Novel Acoustic Sensors for Clinical Applications
SL-86 J.E. Baker

Thrombopoietin is a Novel Cardioprotective Agent: Proofs of Concept Studies in Animal and Human Hearts
SL-87 M. Melnik

Copper(II) Carboxylates as a Perspective Cytotoxic Agents
SL-88 R. Katona

A Combined Artificial Chromosome-Stem Cell Therapy Method for the Treatment of Krabbe's Disease in the Twitcher Mouse
SL-89 S. Hasnain

Bacteria Exhibiting Antimicrobial Activities: Screening for Antibiotics and the Associated Genetic Studies
SL-90 J. Boklan

Targeting Tots: Challenges in Pediatric Cancer Drug Development
SL-91 S.A. Fontana

Pulmonary Drugs from the Sea
B. Geusens

SECosomes for Delivery of siRNA into Cultured Primary Melanocytes and Ex Vivo Human Skin
SL-93 I.A. Mikhailopuloo

A New Strategy for the Synthesis of Nucleosides: One-Pot Enzymatic Transformation of Pentoses into Nucleosides
SL-94 J. Cui

The Voltage Sensors in IKs Channels May be an Ideal Drug Target for Cardiac Arrhythmias
SL-95 T. Yau

Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma
SL-96 M.I. Naash

Compacted DNA Nanoparticles, A Non-Viral Gene Delivery for Ocular Diseases
SL-97 F.C.P. Law

Development and Validation of a Physiologically Based Pharmacokinetic (PBPK) Model of Tamiflu® for the Rat
SL-98 K. Jimbow

Utilization of Melanogenesis Substrate, NPrCAP for Exploiting Melanoma-Targeting Drug and its Conjugation with Magnetite Nanoparticles for Developing Melanoma Chemo-Thermo-Immunotherapy
SL-99 J. Ho

Miniature Pulmonary DNA Vaccination Platform Using Microfluidic Atomization
H.S. Swai

Promising Technology in Addressing Tuberculosis Treatment - Nano Drug Delivery System
SL-101 K. Alexandrov

Novel Cell-Free Protein Expression System Enables Rapid Production and Interaction Analysis of Recombinant Proteins
SL-102 T. Netticadan

Potential of Resveratrol in Preventing the Development of Heart Failure
SL-103 R. Tarnawski

Advanced MRI Imaging in Delineation of Target Volume for Radiotherapy of Differentiated Gliomas
SL-104 E. Ruiz-Hitzky

Nanostructured Biocomposite Materials: New Insights for Biomedical Applications
SL-105 S. Pavel

Development of Photodynamic Therapy for Larger Superficial Skin Mycoses
SL-106 G. Fernandes

n-3 Fatty Acids Prevents Left Ventricular Hypertrophy and Bone Loss Caused by Rosiglitazone Therapy in Diabetic Aging Mice
SL-107 C. Becker

CD4-Mediated Activation of Human Regulatory T Cells and its Potential for Drug Development
H. Lee

Design, Synthesis and Evaluation of New Steroidal Anti-Inflammatory Antidrugs
SL-109 V. Komarov

The New Approach to Affect the Bioavailability of Solid Drugs
SL-110 C. Szabo

The Therapeutic Potential of Hydrogen Sulfide
SL-111 G.M. Saied

Six Months Neoadjuvant Imatinib Improves Respectability Potential of Gastric Stromal Tumors in Egyptian Patients
SL-112 J.Y. Ljubimova

Nanobioconjugate Engineering to Treat HER2/neu Expressing Breast Tumors
SL-113 C.-C. Chou

Differential Heat Stability of Amphenicols and their Relationship to Antimicrobial Activity: Possible Synergism after Heating Treatments
SL-114 T. Jovanovic

Financial Benefit of the Hyperbaric Oxygenation in the Treatment of Mass Non-Infectious Diseases
SL-115 J. Roig

Indacaterol, A Novel Inhaled, Once-Daily, Long-Acting Beta2-Agonist for the Treatment of Obstructive Airways Diseases
SL- 116
J. Rautio

An Effective and Selective Brain Drug Delivery via Amino Acid Prodrugs
SL-117 C. Kaur

Melatonin's Protective Actions on the Developing Brain and Retina Against Hypoxic Damage
SL-118 N.M. Al-Daghri

Vitamin D Status is Associated with Cardiometabolic Risk Factors Among Non-Obese Children and Adolescents
SL-119 B. Maciejewski

Is 7-day-a-week (weekends-in) Accelerated Radiotherapy Beneficial for Locally Advanced Head & Neck Cancer: Results of Two Single-Institution Clinical Trials (CAIR-1 and CAIR-2)
SL-120 T.V. Leshina

Synergy of Drug Transport and Efficacy: Drugs Bound to Glycyrrhizin
SL-121 J. Sancho

Discovery of Specific Inhibitors against Helicobacter pylori by HTS of large Chemical libraries using a Protein Stability Assay
SL-122 M.-C. Wu

Hypoglycemic Effect of Myrtaceae Family Plants in Diabetes
SL-123 L. Valdesoiro

Effectiveness of Omalizumabin Children with Severe Asthma
M. Sedlak

Nanoparticles for Cytosolic Delivery of Important Biomolecular Drug such as DNA, RNA, Peptides and Proteins
SL-125 P. Marits

Sentinel Node-Based Adoptive Immunotherapy of Colon Cancer
SL-126 A.V. Maksimenko

Enzymatic Antioxidants: Next Phase of Pharmacological Effort to Fight Oxidative Stress?
SL-127 R. Suwinski

Implementing the Concept of Multidimensional Radiotherapy into Combined Treatment for Head and Neck Cancer)
SL-128 P. Aranda

Bionanocomposites as Drug Delivery Systems
SL-129 S.Y. Ablordeppey

Novel Anti-Opportunistic Infection Agents with Lower Cytotoxicity
SL-130 D. Shiuan

Virtual Screening for Cholesterol Biosynthesis Inhibitors
SL-131 M. Bosque

Treatment with Omalizmab, in Children with Documented Anaphylactic Reactions to Cow's Milk Protein
COFFEE BREAK : 04:30 - 5:00 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Drug Delivery   Translational Biomedical Research/Central Nervous Systems   Anti-Infectives   Oncology

Pulmonary Disorders

Chairman: A. Banga
Co-Chairman: C. Braeuchle
Chairman: J.M. Brunel
Co-Chairman: J. Benkovic
Chairman: S.O. Bachurin
Co-Chairman: M. Terazima
Chairman: A. Cherkasov
Co-Chairman: S. Mughal
Chairman: H. Lu
Co-Chairman: L. Boukraa
Chairman: J. Fruend
Co-Chairman: G. Ghosez

Chairman: K. Pachmann
Co-Chairman: M. Tanaka

Chairman: A. Linden
Co-Chairman: J. Ho

P. Thordarson

Self-Assembled Gels for Anti-Cancer Drug Delivery
SL-133 M. Cemazar

Tilte Awaited
SL-134 C.O. Rodriguez, Jr

Aerosol Gemcitabine: Preclinical Safety and In vivo Antitumor Activity in Osteosarcoma-Bearing Dogs
SL-135 P. McCluskey

Tilte Awaited
SL-136 G.A. Pianetti

Liquid Chromatography - Tandem Mass Spectrometry for the Simultaneous Quantitation of Artemether and Lumefantrine in Human Plasma: Application for a Pharmacokinetic Study
SL-137 G. Ghosez

Title Awaited
SL-138 B. Blasiak

Evaluation of Iron Based Core Nanoparticles as Targeted Contrast Agents for Molecular IR and MR Imaging of Gliomas
SL-139 K. Khanafer

The Role of Porous Media in Modeling Fluid Flow within Hollow fiber Membranes of the Total Artificial Lungs
J. Ljubimova

Nanopolymers and Phosphodiesterase Type 5 Inhibitors for Drug Delivery into the Brain to Treat Primary Tumors and Metastases
SL-141 M. J. Clark

Tilte Awaited
SL-142 A.Myint

Blood and CSF Kynurenines and Their Clinical Implications in Mood Disorders
SL-143 M.A. Green

Tilte Awaited
SL-144 H.Y.M. Ali

Trial of Lamivudine in Hepatitis B Surface Antigen Carriers with Persistence Hepatitis B Core IgM Antibody
SL-145 C. M. Fusaro

Tilte Awaited
SL-146 C.S. Chen

Molecular Characterization of resistance in multi-targeted tyrosine Kinase Inhibitors and Bcl-2 inhibitors-implication on Clinical Development of small Molecular Targeted Therapy
SL-147 J. Morera

Efficacy of Bosentan in the Treatment of Advanced Pulmonary Fibrosis

Posters Session: 1.00 p.m. - 5.00 p.m. at Corridor

Shopping Visit: Departure 6.20 p.m.

Back to Top

Plenary Session
Time Chairman: A.B. Reitz
Co-Chairman: D.K. Lahiri
Location: Auditorium  Ferid Murad (Nobel Laureate)
 Plenary Lecture
PL-149 Application of Nitric Oxide Research to Drug Development and Disease Therapy

Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8 (Engineering Faculty Area)
Central Nervous System Translational Biomedical Research Cardiovascular/Developments in Other Therapeutic Areas Oncology Successful Drug Discovery from the Research Lab to the Marketplace Drug Discovery and Therapy in the Middle East: Challenges and Opportunities Nanotechnology in Biomedical Research/Proteomics & Bioinformatics/Diabetes & Obesity Regulatory Affairs

Chairman: M. Hajos
Co-Chairman: G.G. Yener
Chairman: J.L. Millan
Co-Chairman: J.J. Powell
Chairman: D. Garcia-Dorado
Co-Chairman: A.A. Ahmed
Chairman: E. Arinc
Co-Chairman: C.S. Chen
Chairman: L.F. Rodella
Co-Chairman: R.J. Reiter

Chairman: R. Chaguture
Co-Chairman: A. Pani

Chairman: G.K. Bonn
Co-Chairman: C.R.S. Garcia

Chairman: A. Hassan
Co-Chairman: V. Thatte
P.A. Guertin

An Innovative Approach to Functional Recovery After Neurological Damage Based Upon An Hypothesis Driven-Technological Platform and Murine Models
IL-150 C.W. Heizman

The Importance of the Calcium-Binding S100 Proteins and their Receptor RAGE in Clinical Diagnostics and as Drug Targets
IL-151 J. Liu

An Enzymatic Approach for Preparing Synthetic Heparin
IL-152 W. Nowicky

Ukrain (NSC 631570) in the Tretment of Prostate Cancer
IL-153 D. Acuna-Castroviejo

Antioxidant and Anti-inflammatory Activity of the Brain Melatonin Metabolites and their Synthetic Analogs: Evaluation in Neurodegenerative Diseases
IL-154 O. Deeb

A Novel Predictive Flip Regression Technique for QSAR of Aromatic Substances:EGFR Inhibitory Activity of Quinazoline Analogues
IL-155 T. Webster

In Situ Nanotechnology-Derived Sensors for Ensuring Implant Success
IL-156 L. Batarsha

Globalization Of the US Food and Drug Administration: International Offices/Middle East Office: Mission and Goals
N.A. Khan

Acanthamoeba and Blood Brain Barrier: The Breakthrough
IL-158 D.K. Banerjee

Targeting N-Glycans for Anti-angiogenic Therapeutics Treating Breast Cancer
IL-159 M. Korbling

Adult Stem Cell Therapy for Injured Solid Organ Tissue
IL-160 F. Huq

Toward New Platinums in Ovarian Cancer
IL-161 J.M. Guerrero

Melatonin as Intracrine, Autocrine, and Paracrine Agent in Immune System: Its Role in Autoimmune Diseases
IL-162 N.S. Turhal

Tolerability of Anthracyclines in Turkish Breast Cancer Patients
IL-163 A. Tamaddoni-Nezhad

Systems Biology of Host-Pathogen Interaction in Campylobacter
IL-164 Wafa Al-Khatib

New Drug Revolution Converting fatal or debilitating Diseases into Manageable therapeutic Options
S.O. Bachurin

Multi-Target Drug Design for New Cognition-Enhancers In Series Of Glutamate-Receptors Ligands
SL-166 R.K. Nath

Type I Collagen Antisense Oligonucleotides for the Treatment of Fibrotic Diseases
SL-167 D.F. Maurizio

Functional Influence of Botulinum Neurotoxin Type A 150kDa Treatment (Xeomin® of Multifocal Upper and Lower limb Spasticity on Chronic Hemiparetic Gait: A Case Report
SL-168 M. Tanaka

Bradeion Project: Monitoring and Targeting of Cancer -- Successful Molecular Marker Diagnosis of Cancer by Fluorescence Correlation Spectroscopy (FCS)
SL-169 G. Escames

Melatonin and its Metabolite AMK Regulate the Proliferation and Differentiation of the Mice Subventricular Neural Stem Cells. Role of Mitochondria
SL-170 A.A. Alamolhoda

The Metal Ions Absorption and Transportation
SL-171 M. Dweik

Novel Implantable Nanobiosensor for Diabetics
SL-172 Y. AlOmi

New Model of Regional Drug and Poisoning Information Center in Saudi Arabia.
(10:45-11:15 am)
COFFEE BREAK : 11:05 – 11:35 a.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8 (Engineering Faculty Area)
Global Discovery Out Sourcing/ Drug Delivery Drug Discovery and Therapy in the Middle East: Challenges and Opportunities/Central Nervous Systems/Global Discovery Outsourcing/Nanotechnology in Biomedical Research Cardiovascular /Developments in Other Therapeutic Areas Oncology Successful Drug Discovery from the Research Lab to the Marketplace Biologics/Central Nervous System

Women’s Health issues

Regulatory Affairs
(Pre/Post Marketing)

Chairman: G. Fricker
Co-Chairman: B. Geusens
Chairman: T. Al-Tel
Co-Chairman: A.A. Alamolhoda
Chairman: J. Liu
Co-Chairman: M. Nowicki
Chairman: W. Nowicky
Co-Chairman: B. Maciejewski
Chairman: K. Moelling
Co-Chairman: M.H. Moghadasian
Chairman: E. Osaro
Co-Chairman: W. Danho

Chairman: H. Borman
Co-Chairman: L. Annamalai

Chairman: M. Abulkhair
Co-Chairman: L. Batarsha

A.K. Saha

Partnerships Between Drug Companies and CROs are Helping Shaps a New Paradigm in Drug Discovery
IL-174 A. Pani

Pharmacologic-Induced Cholesterol Homeostatis Affects Prion Generation in a Synergistic Manner
IL-175 M. Delmar

Cardiac Gap Junctions as Targets for Antiarrhythmic Therapy
IL-176 K. Pachmann

Improving Personalized Cancer Care: Gauging the Response of Circulating Epithelial Tumor Cells (CETC) and Tumour stem Cell Subpopulations to Guide therapy in the Individual Patient
IL-177 M. Labanca

Osteoporosis and Bone Defects in Dentistry: New Drugs and Treatment Options
178 F.C. Onwuka

Effect of Amlodipine, A Calcium Channel Antagonist on Gonadal Steroid of Male Wistar Albino Rats
IL-179 P. Borman

The Treatment of Postmenopausal osteoporosis: An updated Approach
IL-180 D. Vu

Challenges and Opportunities in the Safety Surveillance of Drugs used in the Management of Autoimmune Diseases: "The Canadian Perspectives" and Applicability of the Pharmacovigilance Planning at the Drug Developmental Phase
A. Mohamadzadeh

Prophylactic Effect of Clofibrate in Low Birth Weight Neonates Hyperbilirubinemia
SL-182 F. Zerehsaz

Cutaneous Leishmaniasis, Topical, Safe, Cheap, Effective Herbal Remedy “Z-HE”
SL-183 X.L. Zheng

Uridine Adenosine Tetraphosphate, Up4a: The New Target for Drug Development of Vascular Diseases
SL-184 M. Bauwens

The D-Enantiomer of 2-131i-Phenylalanine as a New Promising Theragnostic in Cancer
SL-185 W.M. Southerland

Genome-Based Drug Design: Understanding the Netropsin-DNA Interaction
SL-186 I.S. Abuljadayel

Retrodifferentiation: A Process of Harnessing Pluripotency Through Cell Surface Receptor Contact of more Mature Somatic Cells
SL-187 J. Kocourkova

Demographic Aspects of Reproductive Health of Women in European Countries
SL-188 V. Thatte

Pre-Market Evaluation and Approval of New Antibiotics in Today’s Climate - A Canadian Perspective
(12:05-12:35 pm)
S.R. Savu

Application of the New Emea Rules to Study Lung Deposition ANS Systemic Exposure of Inhalers: An Evaluation in Three Antiasthmatic Drugs
SL-190 Abolfazl-Movafagh

Application of Phytohaemagglutinin (PHA) mitogenic Effect on Cytogentic and Cell Culture Procedure
SL-191 E. Toverud

Generic Substitution – A Challenge for Adherence in Primary Care and a Reason for Mistakes in Hospitals
SL-192 R.-P Muller

Eight Cycles of Beacopp Escalated Compared with 4 Cycles of Beacopp Escalated Followed by 4 Cycles of Beacopp Baseline with or without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomized HD12 Trial of the German Hodgkin Study Group (GHSG)
SL-193 A.E. Papalois

The Role of Modern Experimental Biomedical Research in the Development of New Products with Clinical Applications. The Example of the Experimental – Research Center ELPEN Pharma
SL-194 J.L. Domingo

Metals and Alzheimer's Disease, Potential, Therapeutic Treatment with Metal Complexing Agents
SL-195 B. Nikolic

GTN in Perimenopause and Menopause – Treatment and Outcome
SL-196 Y. Sharif

Cough and Cold Preparations in UAE Basic Facts and New Regulation Trends

N.R. Biswas

Intraocular Penetration of Orally and Intravenously Administered Fluoroquinolones in Non-Inflamed Eyes of the Patients Undergoing Vitrectomy Surgery
SL-198 J. McGill

The Lilly Phenotypic Drug Discovery (PD2) Initiative: An Invitation to an Open Innovation Model in Drug Discovery
SL-199 A.A. Batista

Antimalarial Activities of Phosphine / Ruthenium Complexes
SL-200 E. Terpos

Proteasome Inhibition Therapies in the Management of Patients with Multiple Myeloma
SL-201 Y. Taiwo

Eli Lilly External Pharmaceutical Innovation Partnering Strategies
SL-202 M. R. Hwu

Tilte Awaited
SL-203 S. Jacob

Current Therapies in Irritable Bowel Syndrome
SL-204 R.S.I. Hassan

Evaluation of Pharmaceutical Inspection Practices
(01:05:01:25 pm)

K. Jomova

The Role of Transition Metals and Irradiation in the Action of Anticancer Drug Campthothecin
SL-206 J. Szebeni

Mechanisms and Approaches for the Prevention of Adverse Immune Reactions to Nanomedicines
SL-207 R.S. da Silva

Nitric Oxide Donors Based on Ruthenium Complexes. Cytotoxical Photobiological and Pharmacological Aspects
SL-208 L. Miszczyk

An Evaluation of Half-Body Irradiation (HBI) as the Treatment of Cancer Patients with Widespread, Painful Bone Metastases
SL-209 J.J. Yu

New Platinum Drug Dicycloplatin Appears Effective in Treating Brain and Prostate Cancers
SL-210 J. Jimeno

Tilte Awaited
SL-211 L.C. Larabie

Leaving the Pack Behind: Implications of Spontaneous Quitting for Women Smokers
SL-212 Tilte Awaited
(01:15-01:35 pm)
LUNCH BREAK : 1:25 – 03:00 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8 (Engineering Faculty Area)
Enabling Technologies/Deve-lopments in Other Therapeutic Areas Proteomics & Bioinformatics Drug Discovery & Therapy in the Middle East: Challenges & Opportunities Cardiovascular/Oncology Endothelial Dysfunction in Cardiovascular Diseases /Nanotechnology in Biomedical Research/Pharmaceutical Biotechnology Central Nervous System Women's Health Issues Regulatory Affairs
Chairman: E. Toverud
Co-Chairman: P.E. Zollinger
Chairman: P. Hobza Co-Chairman: I.H. Khan Chairman: O. Deeb
Co-Chairman: J.A. Vaz
Chairman: M. Delmar
Co-Chairman: R. Suwinski
Chairman: A. Roman
Co-Chairman: T. Webster
Chairman: M. Bajbouj
Co-Chairman: N.A. Khan

Chairman: S. Jacob
Co-Chairman: L.C. Larabie

Chairman: A. Hassen
Co-Chairman: S. Ghani

S. McN. Sieburth

Silicon-Based Protease Inhibitors - Advances in Chemistry and Applications
IL-214 G.K. Bonn

New Analytical Technologies for Applications in Proteomics
IL-215 V. Misik

Globalization of Pharma Development – role of Middle East
IL-216 J. Gutkowska

Oxytocin: Old Hormone, New Drug
IL-217 L. Dos-Surbia

Pulmonary Hypertension in Congenital Heart Diseases. Role of Pulmonary Vasodilators Drugs in this Clinical Setting
IL-218 A.W. Klein

Toxic Toxins: 2010
IL-219 H. Borman

Breast Reduction in Women: Aesthetic and Health Benefits
IL-220 S. Ghani

Global Perspective of Stability Testing
S. Grmec

Erythropoietin Facilitates the Return of Spontaneous Circulation and Survival inVictims of Out-of-Hospital Cardiac Arrest
SL-222 R. Graziella

Forced Unbinding of GPR17 Ligands from Wild Type and R2551 Mutant Receptor Models through a Computational Approach
SL-223 J. Hasegawa

Tilte Awaited

SL-224 C. Szczepanski

A New Lytic Peptide for the Treatment of Cancer
SL-225 K. Karim

Smart Materials for Pharmaceutical Industry
SL-226 F. Deschamps

Aluminium Discovery in Occupational Health
SL-227 L. Annamalai

Angiogenic Factors and their Role in Uteroplacental Dysfunction
SL-228 M. Abuelkhair

Introduction of Generic Drug Policy in the Market Place with Special Reference to the Health Authority in the Emirates of Abudhabi
P. Takac

Discovery of the Biologically Active Compounds from the Insect Salivary Glands as a Potential Drugs
SL-230 N. Nomura

Tilte Awaited

SL-231 M.R. F. Wessels

Tilte Awaited

SL-232 M.H. Bukhari

Molecular Classification of Breast Cancer and Role of Immunohistochemistry for detection of cell types that predicts response to chemotherapy
SL-233 T. Wenyi

Paclitaxel Production Using Co-culture of Taxus Suspension Cells and Paclitaxel-Producing Endophytic Fungi in a Co-Bioreactor
SL-234 H. Vial

Tilte Awaited

SL-235 O. Piccolo

Tilte Awaited

SL-236 O. G. Al Ahdab

Pharmacoeconomics: The Fourth Hurdle to Marketing and Formulary Access
COFFEE BREAK : 4:10 – 5:00 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8 (Engineering Faculty Area)
Oncology - Endothelial Dysfunction in Cardiovascular Diseases - Cardiovascular/ Pulmonary Disorders Central Nervous System


Chairman: M. Melnik
Co-Chairman: R. Tarnawski
Chairman: N. Nomura Co-Chairman: J. Fruend Chairman: E. Domingo
Co-Chairman: L.Dos-Surbia

Chairman: P. McCluskey Co-Chairman: M. A. Green Chairman: C.D. Ribas
Co-Chairman: M. Korbling
Chairman: M. Labanca
Co-Chairman: M. Zhinan

Chairman: S.Y. Ablordeppey
Co-Chairman: J. Sancho

S. Pervaiz

Regulation of Mitochondrial Metabolism: Yet Another Facet in the Intriguing Biology of the Onco-Protein Bcl-2
IL-238 Y. Wang

Title Awaited
IL-239 F. Lozano

Premature Ejaculation. Pharmacological Treatment
IL-240 I. Kato

Title Awaited
241 K. Balagurunathan

Developments of Novel Anticoagulants
IL-242 M. Diksic

Imaging of Serotonin synthesis as a Factor of Serotonergic Transmission and Brain Serotonergic Receptors and Their Relation to Affective Disorders
IL-243 H. Lu

Utilization Analysis of Drug Efficacy of the 329 Cases of Wenchuan Earthquake Women and Children Patients
IL-244 Title Awaited

R. Kumar

Role of PET and PET-CT in Anticancer Drug Development
IL-246 J. st-Amand

Title Awaited
IL-247 E. Ruiz-Castane

Total Penile Reconstruction. Faloplastia
IL-248 R.S. Wallis

Title Awaited
IL-249 C.S. Ulrik

Anti-Inflammatory Therapy and Decline of Lung Function in Patients with Asthma
IL-250 S. Ghandour

Brain Drug Targeting and Noninvasive Delivery of Therapeutics
IL-251 L. Boukraa

Bee Products as Anti-infective Agents
IL-252 Title Awaited


Posters Session: 1.00 p.m: – 5.00 p.m. at Corridor

Gala Dinner at Dhow Cruise: Departure at 6:15 p.m.

The buses will leave for Hotels at: 9.00 p.m.

Back to Top

Plenary Session
Time Chairman: J. Lewis
Co-Chairman: C. Hopkins
Location: Auditorium David Kerr PL-254 Innovations in Cancer Drug Development

Lecture Hall
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)

Developments in Other Therapeutic Areas/Global Roundup of Pharmaceutical Research Capabilities & Opportunities Proteomics & Bioinformatics Translational Biomedical Research Global Discovery Outsourcing/Oncology Endothelial Dysfunction in Cardiovascular diseases Central Nervous System

Inflammation & Immunology

Regulatory Affairs
(REC Local)

Chairman: B.M. Dunn
Co-Chairman: A. Nefzi
Chairman: P. Hobza
Co-Chairman: G.K. Bonn
Chairman: J.K. Yao
Co-Chairman: L. Kostrikis
Chairman: A.K. Saha
Co-Chairman: M. Bauwens

Chairman: Y. Xia
Co-Chairman: E. Ruiz-Castane
Chairman: A.W. Klein
Co-Chairman: L. Lagae
Chairman: O. Winqvist
Co-Chairman: S. Basu

Chairman: M. Al-Farhan
Co-Chairman: K. Obaidi

M.I. Choudhary

Novel Pharmacophores from Natural Sources-Discovery Development
IL-255 C.R.S. Garcia

Malaria Functional Genomics: A Plasmodium Receptor for C Kinase (PfRack) Modulates Calcium Signaling in Mammalian Cells
IL-256 H.M. Amin

NPM-ALK+ T-Cell Lymphoma as a Model for Developing Cancer Therapeutics
IL-257 J. Freire

Drug Discovery Outsourcing: Experiences and Learnings
IL-258 M.A. Gomez Sanchez

Evolution of Prostaglandins in the Treatment of Pulmonary Hypertension
IL-259 V. Parpura

Carbon Nanotubes as Modulators of Neuronal Growth
IL-260 C. L. Verweij

Biomarkers in Targeted-Drug Development for Chronic Inflammatory Diseases
IL-261 M. A. Sharifi

Institutional Regulations for Biomedical Research: The Role of "Institutional Review Board" (IRB)
C.E. Stout

Mixing Ecology and Drug Discovery. An Innovative New Model
IL-263 I.H. Khan

New Paradigm in Tuberculosis Serodiagnosis: Computational Analysis to Classify Profiles of anti-Mtb. Antibodies Detected by Multiplex Microbead Array
IL-264 N.J.R. Faria

Novel in vitro Assay for the Characterisation of Phosphate Binders: Efficacy of IMH-Based Materials
IL-265 D.M. Stout

Outsourcing Drug Discovery at Merck: Future Trends
IL-266 A. Roman

Medical Treatment of PAH and the Role of Lung Transplantation in 2010
IL-267 M. Bajbouj

Electromagnetic Interventions to treat Depression
IL-268 N. Nishimoto

Tocilizumab, a New Therapeutic Antibody Inhibiting IL-6 Action, for Immune Inflammatory Diseases Inclding Rheumatoid Arthiritis and Juvenile Idiopathic Arthritis. Mechanisms of Action and Prediction for the Clinical Efficacy Using DNA Microarray
IL-269 M.M. Al-Turki

Research Regulations at the King Faisal Specialist Hospital and Research Centre (KFSH&RC) – Riyadh, Saudi Arabia
O.L. Franco

The Utilization of Proteomics and Gel-Free Peptidomics to Find Novel Plant Antimicrobial Peptides and to Understand the Relative Bacterial Resistance
SL-271 H. Durchschlag

Prediction of Volume, Surface, and Hydration Properties of Proteins and Other Biomolecules
SL-272 J. Chandra

Translational Cancer Research Using Novel Clinically Relevant Proteasome Inhibitors and Histone Deacetylase Inhibitors
SL-273 F. Andrae

UKRAIN based Laser Therapy in Oncology
SL-274 M. Sinz

Title Awaited
SL-275 J.J. Greer

Development of AMPAKINE Therapy to Alleviate Drug-Induced Respiratory Depression
SL-276 S. Zughaier

Potent Anti-inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine Analogs

SL-277 M. Zemni

Local Ethics Committees and Research: The Tunisian Experience
COFFEE BREAK : 11:05 - 11:35 a.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Developments in Other Therapeutic Areas/Enabling Technologies  Drug Delivery Translational Biomedical Research Oncology Successful Drug Discovery from the Research Lab to the Marketplace Central Nervous System

Inflammation & Immunology

Regulatory Affairs (REC)

Chairman: P. Takac
Co-Chairman: A.A. Batista
 Chairman: H. Kasuya
Co-Chairman: H. Lee
Chairman: D.K. Banerjee
Co-Chairman: : I.M. Shah

Chairman: R.-P. Muller
Co-Chairman: F.Huq
Chairman: W.M. Southerland
Co-Chairman: J.J. Yu
Chairman: S. Ghandour
Co-Chairman: S.R. Maudsley

Chairman: C.L. Verweij
Co-Chairman: P.C. Heinrich

Chairman: M. Al Farhan
Co-Chairman: M. Zimni

D.B. Shukla

Synergy of Intellectual Property and Traditional Knowledge
SL-279 K.A.M. Gasem

Virtual Design of Chemical Penetration Enhancers for Transdermal Drug Delivery of Insulin
SL-280 M. Terazima

How to Measure Translational Diffusion of Chemically Reactive Drugs
SL-281 M. Hassan

Pharmacokinetics and Biodistribution of CDK Inhibitors as Anticancer Drugs
SL-282 C.E.J. van Rensburg

Potassium Humate Reduces Clinica (WOMAC) and Bioligical (hs-CRP) Markers of Disease in Patients with Osteoarthritis of the Knee
SL-283 A. Higaz

Blood Brain Barrier Permeability and tPA-Mediated Neurotoxicity
SL-284 P. Lukasiak

Genetic Vaccine Decision Support System
SL-285 G. Wajid

A Strategy for Streamlining Health Research in United Arab Emirates
(11:35-12:05 pm)

G. Orizio

Internet and the Drug Market: The New Scenario Created by Cyberpharmacies
SL-287 T. Mizushima

Therapeutic Effect of Lecithinized Superoxide Dismutase (PC-SOD) on idiopathic Pulmonary Fibrosis in Human and Bleomycin-induced Pulmonary Fibrosis in Mice
SL-288 J.L. Millan

Leads and Target Validation for the Prevention and Treatment of Vascular Calcification
SL-289 W. Voigt

Session Lecture:
The New Platinum Compound cis-Dichloro(2-{11-[(tetrahydro-2H-pyran-2-yl)oxy] undecyl} propan-1,3-diamino)plantin (II) overcomes CDDP resistance and induces a DNA-independent and caspase-independent apoptotic cell death in testicular cancer
SL-290 J.A. Vaz

Challenges in Clinical Drug Development
SL-291 N.N. Gorgani

Ring Stabilizers: Compounds that Increase Dynamin GTPase Activity by Promoting Ring Assembly
SL-292 A.Rengasamy

Utilization of Translational "Bench-to-Bedside" Clinical Protocols to Elucidate the Roles of FK Binding Proteins and Cyclophilins in Mediating Human T cell-Mediated Macrophage Activation
SL-293 G. Al Tajir

Research Ethics Committee in the UAE
P.E. Zollinger

The Administration of Vitamin C in Prevention of CRPS-I in Traumatology and Orthopaedic Surgery
SL-295 B.M. Wozniewicz

Discovery of the New Biotechnological Procedure of Generation and Identification of Thymic Epithelial Progenitor Cells by In vitro Processing of Hyman Thymic Fragments for Allotransplantation – Possible Clinical Application in Aging Carriers
SL-296 J.J. Powell

IMH-Based Materials Bind Dietary Phosphate Effectively In Vivo
SL-297 R.M.A. Marretta

Session Lecture:
On Cancer Cell Cycle and Universal Apoptosis Parameters Signaling Unravelled in Silico
SL-298 S.S. Redzic

The Endemic Vascular Plants as a Source of New Medicines
SL-299 Y. Iwasaki

Atrovastratin Protects Spinal Motor Neurons from Glutamate Mediated Neurotoxicity
SL-300 J. Xiang

A Distinct Role of CD4+ Th17 and Th17-stimulated CD8+ CTL in Induction of Experimental Autoimmune Encephalomyelitis and Antitumor Immunity
SL-301 T. Antoinne

Research Ethics Committees MENA Watch
(12:25-12:45 pm)


Prospects of Drug Discovery by NMR Enhanced by Dynamic Nuclear Polarization
SL-303 M.B. Bolger

Nanoparticle Dissolution and Absorption: Biopharmaceutics Physical Pharmacy, and Simulation
SL-304 L. Kostrikis

HIV-1 Integrase Inhibitors: Role of Natural Diversity on Drug Efficacy and Resistance
SL-305 M. El Habbash

Progress in Rituximab
SL-306 G. Simon

Title Awaited
SL-307 V. Brabec

Title Awaited
SL-308 D. Delgado

The Human Leukocyte Antigen-G Molecule: A Novel Marker and Therapeutic Tool in Human Transplantation
SL-309 H. Gharibyar

Oversight of Clinical Research – The Health Authority Abu Dhabi Perspective

LUNCH BREAK 12:55 - 2:15 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8
(Engineering Faculty Area)
Generic Pharmaceuticals: Challenges and Opportunities/Developments in Other Therapeutic Areas Successful Drug Discovery from the Research Lab to the Market Place/ Drug Discovery & Therapy in the Middle East: Challenges & Opportunities Translational Biomedical Research/Nanotechnology in Biomedical Research Endothelial Dysfunction in Cardiovascular Diseases /Oncology Biologics Central Nervous System

Inflammation & Immunology

Chairman: M.I. Choudhary
Co-Chairman: S. Grmec

Chairman: R. Mora-Ripoll
Co-Chairman: D.L. Vesely
Chairman: C.W. Heizman
Co-Chairman: J. Jimbow

Chairman: N.H. Hadi
Co-Chairman: L. Miszczyk

Chairman: E. Osaro
Co-Chairman: C. Godwin
Chairman: J.J. Greer
Co-Chairman: V. Parpura

Chairman: O. Winqvist
Co-Chairman: J. Xiang

Chairman: G.A. Pianetti
Co-Chairman: S. Hasnain

M. Nowicki

Biosimilar Medical Agents Approval in the European Union - a Short but Fascinating Story
IL-311 P. Watt

Phylomer Libraries as a Rich Source of Potent Bioactive Peptides
IL-312 I.M. Shah

Pharmacogenetics of Cytochrome 2D6: A Translational Medicine Perspective
IL-313 R. A. Torres

New Concepts in the Non Invasive Evaluation of Remodeling of the Right Ventricle in Pulmonary Arterial Hypertension: Future Targets for Drug Evaluation
IL-314 J. Weigelt

Systematic Generation of Renewable Antibodies for Epigenetic Proteins to Enable Target Validation
IL-315 L. Lagae

The Need for New Treatment Options in Refractory Epilepsy
IL-316 S. Basu

Novel Bioactive Prostaglandins and Isoprostanes in Health and Inflammatory Diseases
IL-317 B.L. Tekwani

Global Challenges for New Drug Discovery Against Tropical Parasitic Diseases: Multidirectional Molecular Targets-Based Strategies
Z. Kacarevic-Popovic

On the Use of Radiation Technology for Nanoscale Engineering of Silver/Hydrogel Based Nanocomposites for Potential Biomedical Application
SL-319 D. Lazic

Destruction and Autodestruction Versus Maladaptation and Drug Therapy
SL-320 H. Fenniri

Self-Assembled Nano-scaffolding for Tissue engineering and Drug Delivery
SL-321 A.A. Udelnow

Omeprazole inhibits Proliferation and Induces Autophagy in Pancreatic Cancer Cells
SL-322 W. Danho

Therapeutic Peptides: Opportunities and Challenges
SL-323 S.R. Maudsley

Bioinformatic Approaches to Signaling/Metabolic Pathways Analysis. Crucial Tools for Novel Therapeutic Design
SL-324 A.J. Melendez

Role of SphK1 in TLRs Signaling and Sepsis: Therapeutic Inhibition of SphK1 is Protective in Experimental Endotoxin shock and Polymicrobial Sepsis
SL-325 S. Farshad

Emergence of Multi Drug Resistant Strains of s Isolated from Urinary Tract Infection
A.A. Ahmed

Role of Pathology and Immunohistochemistry in the Modern Era of Molecular Therapy
SL-327 D. Macesic-Petrovic

Behavioral Disorders and Drug Therapy
SL-328 C. Mello

Microstructures Formation in a Seemingly Ideal Homogeneous Mixture of Ethanol and Methanol: An Experimental Evidence and Two-Dimensional Correlation Spectroscopy Approach
SL-329 N. Kasahara

Preclinical Development and Clinical Translation of Tumor-Selectively Replicating Retrovirus Vectors
SL-330 J. Watson

Session Lecture: Cell Based Bioassays for the Validation of Biosimilars
SL-331 M. Zhinan

Loureirin B: A Novel Chemical Component which can Modulate Voltage-gated Sodium Currents through TRPV1 Receptor
SL-332 P.C. Heinrich

A Fusion Protein of the Ligand – Binding Domain of the IL-6 Receptor Alpha and the Signal Transducer gp130 Acts as a Highly Potent and Specific Inhibitor of Human IL-6
SL-333 E.H.A. Kamel

Cymetiron (Hepron-BM) as Initial Treatment for Chronic Hepatitis C
R.A. Assaly

Title Awaited
SL-335 N.S. Trotter

Title Awaited
SL-336 L.-J. Fortin

Title Awaited
SL-337 J. Liu

Effect of One Low Molecular Weight Polysaccharide (LMW-ABP) from Agaricus blazei on Inhibiting Sialyl Lewis X/E-Selectin-Mediated Metastatic Potential in HT-29 Cells and its Mechanism
SL-338 D. Coster

Biologics for Eye Disease
SL-339 Y. Xia

Activation of δ-Opioid Receptors Protects Against Anoxic Disruption of Ionic Homeostasis in the Cartex
SL-340 M. Weber

The Intravenous Laser Blood Irradiation, a new Therapeutic Approach in Immunology and Cancer Therapy
SL-341 C.G. de Oliveira

Title Awaited

COFFEE BREAK : 3:45 – 4:15 p.m.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No.
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
Lecture Hall No. 8 (Engineering Faculty Area)
Successful Drug Discovery from the Research Lab to the Market Place Developments in Other Therapeutic Areas Translational Biomedical Research   Global Roundup of Pharmaceutical Research Capabilities & Opportunities  


Chairman: T. Tallberg
Co-Chairman: D. Acuna-Castroviejo

Chairman: R.S. da Silva
Co-Chairman: D.B. Shukla
Chairman: A. Mufti
Co-Chairman: K.A. Baig

Chairman: J.M. Brunel
Co-Chairman: M. Barton

Chairman: C.E. Stout
Co-Chairman: A.B. Reitz
Chairman: A. Cherkasov
Co-Chairman: H. Conoly
Chairman: M. Cemazar Co-Chairman: M. J. Clark Chairman: P. McCluskey
Co-Chairman: G. Ghosez
M.H. Moghadasian

Cycloartenol: A New Dietary Agent with Significant Cardiovascular Benefits
IL-343 K.M.A. Gasem

Effect of Different Enhancers on the Transdermal Permeation of Insluin Analogs
IL-344 O.A. Gressner

Identification of Paraxanthine as the Most Potent Inhibitor of Hepatocellular Connective Tissue Growth Factor Expression Among the Three Primary Caffeine Metabolites
IL-345 S.A. Day

Title Awaited
IL-346 A.K. Saha

Outline of Drug Discovery Partnerships between Western Pharma and Indian Laboratories
IL-347 C.K. Rha

Title Awaited
IL-348 H.T. Wehrens

Title Awaited
IL-349 N. Bela

Title Awaited

Posters Session: 1.00 p.m. – 5.00 p.m. at Corridor

City visit: Departure: 5.30 p.m.

IMPORTANT: The buses will leave daily from all Hotels at 8.15 a.m. for the conference venue.

Back to Top

| Conferences & Trade shows |
[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy